                         SEQUENCE LISTING

<110>  DUKE UNIVERSITY
 
<120>  COMPOSITIONS AND METHODS FOR DONOR SELECTION AND PROGNOSIS OF 
       ACUTE GRAFT-VERSUS-HOST DISEASE

<130>  D118 1240WO / DU6176PCT

<150>  62/659,807
<151>  2018-04-19

<160>  10    

<170>  PatentIn version 3.5

<210>  1
<211>  23
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  miRNA hsa-miR-142-3p

<400>  1
uguaguguuu ccuacuuuau gga                                               23


<210>  2
<211>  21
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  ath-miR159a

<400>  2
uuuggauuga agggagcucu a                                                 21


<210>  3
<211>  49
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  RT primer 159aRT

<400>  3
gtcgtatcca gtgcagggtc cgaggtattc gcactggata cgactagag                   49


<210>  4
<211>  17
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Probe 159aP

<400>  4
ctggatacga ctagagc                                                      17


<210>  5
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  qPCR 5p primer 159aF

<400>  5
gccgtttgga ttgaagggag c                                                 21


<210>  6
<211>  16
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  qPCR 3p primer UPR

<400>  6
gtgcagggtc cgaggt                                                       16


<210>  7
<211>  51
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  RT primer 142-3pRT

<400>  7
gtcgtatcca gtgcagggtc cgaggtattc gcactggata cgactccata a                51


<210>  8
<211>  18
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Probe 142-3pP

<400>  8
ctggatacga ctccataa                                                     18


<210>  9
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  qPCR 5p primer 142-3pF

<400>  9
cgccgctgta gtgtttccta cttt                                              24


<210>  10
<211>  16
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  qPCR 3p primer UPR

<400>  10
gtgcagggtc cgaggt                                                       16


